VPGMarketResearch.com is a notable management consulting and research agency rendering high rate services to corporate executives and top decision makers. VPGMarketResearch.com conducts syndicated and custom research across the following industries:
- Biotechnology
- Chemicals
- Food processing
- Electronics
- Healthcare
- Pharmaceuticals
Close national and global links have been established with public-sector and financial bodies, governments, other research agencies, top executives and experts that extremely enriched VPG’s capabilities to provide extensive and relevant studies. This much contributed to the database creation that contains materials on a great number of markets, industrial sectors, companies, products, technologies, key market participants and management boards. For today more than 1,000 companies from 70 countries are in VPG’s client network. VPG market reports comprise essential knowledge including:
- Market segmentation
- Competitive landscape
- Regulatory policies
- Latest technology trends
- Acquisition evaluations
- Vendors’ analysis, etc.
Publications found:
54,544
Sort by:
2021-2025 Asia-Pacific Tumor Markers Business Opportunities in 17 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 14,500.00
This new 17-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...
November 2021
2021-2025 Europe Tumor Markers Business Opportunities-France, Germany, Italy, Spain, UK-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 14,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the European cancer diagnostics market during the next five years. The report examines trends in major...
November 2021
2021-2025 Europe Tumor Markers Business Opportunities in 38 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 24,500.00
This new 38-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...
November 2021
2021-2025 France Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the French cancer diagnostics market during the next five years. The report examines trends in the Fre...
November 2021
2021-2025 Germany Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the German cancer diagnostics market during the next five years. The report examines trends in the Ger...
November 2021
2021-2025 Global Tumor Markers Business Opportunities-USA, Europe, Japan-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 24,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S...
November 2021
2021-2025 Italy Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the Italian cancer diagnostics market during the next five years. The report examines trends in the It...
November 2021
2021-2025 Japan Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the Japanese cancer diagnostics market during the next five years. The report examines trends in the J...
November 2021
2021-2025 Latin America Tumor Markers Business Opportunities in 22 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 14,500.00
This new 22-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...
November 2021
2021-2025 Middle East Tumor Markers Business Opportunities in 11 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 9,500.00
This new 11-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...
November 2021
2021-2025 North America Tumor Markers Business Opportunities-USA, Canada, Mexico-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 9,500.00
This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific inf...
November 2021
2021-2025 Spain Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the Spanish cancer diagnostics market during the next five years. The report examines trends in the Sp...
November 2021
2021-2025 U.K. Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the UK cancer diagnostics market during the next five years. The report examines trends in the UK canc...
November 2021
2021-2025 U.S. Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the U.S. cancer diagnostics market during the next five years. The report examines trends in the U.S....
November 2021
2021-2025 World Tumor Markers Business Opportunities in 97 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 34,500.00
This new 97-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test. The report is available by section, and can be customized to spe...
November 2021
Europe Molecular Diagnostics Market Assessment-France, Germany, Italy, Spain, UK-2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 17,500.00
This new comprehensive five-country report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities eme...
November 2021
North America Molecular Diagnostics Market Assessment of the US, Canada and Mexico-2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 9,500.00
This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is designed to help current suppliers and potential market ent...
November 2021
2021-2025 Asia-Pacific Immunodiagnostics Market Perspective for 17 Countries—Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer Diagnostic, Endocrine, Immunoprotein, TDM, and Special Chemistry Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 14,500.00
This new 17-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...
November 2021
2021-2025 Europe Immunodiagnostics Market Perspective for 38 Countries—Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer Diagnostic, Endocrine, Immunoprotein, TDM, and Special Chemistry Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 24,500.00
This new 38-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...
November 2021
2021-2025 Europe Immunodiagnostics Market Perspective-France, Germany, Italy, Spain, UK-Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer Diagnostic, Endocrine, Immunoprotein, TDM, and Special Chemistry Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 14,500.00
LeadingMarketResearch.com's new report is a five-country strategic analysis of major business opportunities emerging in the European immunodiagnostic market during the next five years. The report is a...
November 2021
2021-2025 Europe Virology and Bacteriology Market for over 100 Tests: France, Germany, Italy, Spain, UK-Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation, Opportunities
US$ 14,500.00
This unique report from LeadingMarketResearch.com provides data and analysisnot available from any other published source, including test volume and sales forecasts for 100 individual tests, and compe...
November 2021
2021-2025 Global Immunodiagnostics Market Perspective-USA, Europe, Japan-Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer Diagnostic, Endocrine, Immunoprotein, TDM, and Special Chemistry Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 24,500.00
LeadingMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging in the immunodiagnostic market during the next five years. The report is available...
November 2021
